# Etomidate/Propofol Mixture or Propofol Monotherapy Use in Patients Undergoing General Anesthesia

> **NCT03855267** · NA · UNKNOWN · sponsor: **Guolin Wang** · enrollment: 200 (estimated)

## Conditions studied

- Etomidate is Mixed With Propofol

## Interventions

- **DRUG:** Propofol 20 MG/ML
- **DRUG:** Propofol 20 mg/ml , etomidate 2 mg/ml

## Key facts

- **NCT ID:** NCT03855267
- **Lead sponsor:** Guolin Wang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-12-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03855267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03855267, "Etomidate/Propofol Mixture or Propofol Monotherapy Use in Patients Undergoing General Anesthesia". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03855267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*